BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol 2023; 29(37): 5292-5304 [PMID: PMC10600802 DOI: 10.3748/wjg.v29.i37.5292]
URL: https://www.wjgnet.com/2308-3840/full/v29/i37/5292.htm
Number Citing Articles
1
Vasiliy I Reshetnyak, Igor V Maev. Bile acid therapy for primary biliary cholangitis: Pathogenetic validationWorld Journal of Experimental Medicine 2025; 15(1): 101771 doi: 10.5493/wjem.v15.i1.101771
2
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
3
Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guocai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng. Advances, challenges and future applications of liver organoids in experimental regenerative medicineFrontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1521851
4
Filippo Gabrielli, Eleonora Crepaldi, Alessia Cavicchioli, Marco Rivi, Arianna Carmen Costanzo, Carmela Cursaro, Pietro Andreone. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus TreatmentsBiomolecules 2024; 14(10): 1227 doi: 10.3390/biom14101227
5
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitisExploration of Immunology 2024; : 624 doi: 10.37349/ei.2024.00163